Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2020

01-02-2020 | NSCLC | ASO Author Reflections

ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery

Authors: Han-Yu Deng, MD, Qinghua Zhou, MD

Published in: Annals of Surgical Oncology | Issue 2/2020

Login to get access

Excerpt

Current guidelines recommend systematic lymph node (LN) dissection (SLND) or sampling for treating early-stage non-small cell lung cancer (NSCLC).1 However, the optimal extent of LN dissection for early-stage NSCLC remains controversial, as lobe-specific LN dissection (L-SLND) has been recently advocated as a minimally invasive alternative to SLND for treating early-stage NSCLC.2 Also, our previous study showed that L-SLND could yield a lower risk of postoperative morbidity than SLND without compromising oncological outcomes.2 However, in previous studies, the extent of L-SLND also remains unclearly defined without widely accepted recommendation.3 Therefore, how to perform L-SLND for early-stage NSCLC requires further in-depth investigation. …
Literature
1.
Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S–e313S.CrossRef
2.
Deng HY, Qin CL, Li G, et al. Can lobe-specific lymph node dissection be an alternative to systematic lymph node dissection in treating early-stage non-small cell lung cancer: a comprehensive systematic review and meta-analysis? J Thorac Dis. 2018;10(5):2857–2865.CrossRef
3.
Han H, Chen H. Selective lymph node dissection in early-stage non-small cell lung cancer. J Thorac Dis. 2017;9(7):2102–2107.CrossRef
4.
Metadata
Title
ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery
Authors
Han-Yu Deng, MD
Qinghua Zhou, MD
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07946-z

Other articles of this Issue 2/2020

Annals of Surgical Oncology 2/2020 Go to the issue

Health Services Research and Global Oncology

Size and Importance of Socioeconomic Status-Based Disparities in Use of Surgery in Nonadvanced Stage Gastrointestinal Cancers

ASO Author Reflections

ASO Author Reflections: Nodal Disease in Recurrent Oropharynx

Colorectal Cancer

Extended Radical Resection: The Standard of Care for Patients with Advanced Pelvic Malignancy

ASO Author Reflections

ASO Author Reflections: Melanoma Patients with a Local Recurrence or In-Transit Metastasis: Sentinel Node Biopsy to Identify Those at Highest Risk of Metastases and Death

ASO Author Reflections

ASO Author Reflections: Anastomotic Complications are More Prevalent in Laparoscopic Total Gastrectomy than in Open Total Gastrectomy

Melanoma

Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis